A detailed history of North Crest Asset Manangement, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, North Crest Asset Manangement, LLC holds 5,514 shares of UTHR stock, worth $2.06 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
5,514
Previous 5,276 4.51%
Holding current value
$2.06 Million
Previous $1.68 Million 17.56%
% of portfolio
0.06%
Previous 0.06%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$311.04 - $363.55 $74,027 - $86,524
238 Added 4.51%
5,514 $1.98 Million
Q2 2024

Jul 16, 2024

BUY
$228.26 - $319.04 $228 - $319
1 Added 0.02%
5,276 $1.68 Million
Q1 2024

Apr 15, 2024

SELL
$210.76 - $249.51 $12,645 - $14,970
-60 Reduced 1.12%
5,275 $1.21 Million
Q1 2022

Apr 18, 2022

BUY
$166.16 - $213.96 $13,292 - $17,116
80 Added 1.52%
5,335 $957,000
Q4 2021

Feb 09, 2022

BUY
$184.32 - $216.08 $968,601 - $1.14 Million
5,255 New
5,255 $1.14 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $17B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track North Crest Asset Manangement, LLC Portfolio

Follow North Crest Asset Manangement, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of North Crest Asset Manangement, LLC, based on Form 13F filings with the SEC.

News

Stay updated on North Crest Asset Manangement, LLC with notifications on news.